Deaconess says it has received a newly-released COVID-19 treatment that will be used to treat mild-to-moderate cases of COVID-19 in patients who are at high risk of progressing to severe COVID-19 and/or hospitalization.
Deaconess says it has received a newly-released COVID-19 treatment that will be used to treat mild-to-moderate cases of COVID-19 in patients who are at high risk of progressing to severe COVID-19 and/or hospitalization.
Wevv dot com.
But deaconess isn't just testing patients it's also treating them with eli lilly's new antibody drug.
We first reported on friday --- 2750 doses were distributed across indiana.
We now know --- 180 doses were given to deaconess hospitals.
Since it's arrival -- doctors were able treat 30
In the lead up to World No Tobacco Day later this month, it is high time we recognise and effectively address the deadly synergy..
A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging..